Why is ANG Lifesciences falling/rising?

As of 28-Oct, ANG Lifesciences India Ltd is experiencing a decline in its stock price, currently at 32.69, which reflects a decrease of 0.3 or 0.91%. The stock has underperformed its sector by 0.65% today, despite showing higher performance than its 5-day, 50-day, and 100-day moving averages. However, it remains below its 20-day and 200-day moving averages. Over the past week, the stock has gained 4.11%, but it has seen a decline of 2.62% over the past month and a significant drop of 26.85% year-to-date. The recent increase in investor participation, with a delivery volume rise of 58.68% against the 5-day average, indicates some interest, but overall, the stock has faced substantial losses over longer periods, including a 77.45% decline over three years.
In the broader market context, while ANG Lifesciences has shown a positive return in the short term compared to the benchmark Sensex, which gained only 0.24% over the past week, its longer-term performance is starkly negative. The Sensex has increased by 5.22% over the past month and 8.30% year-to-date, highlighting a significant divergence between the stock's performance and that of the broader market. This contrast suggests that while there may be some short-term recovery, the overall trend for ANG Lifesciences remains concerning, particularly given its substantial underperformance over the past year and three years compared to the benchmark.